SGLT2 inhibitors in Heart Failure











>> YOUR LINK HERE: ___ http://youtube.com/watch?v=T5Zhof_6-3Q

SGLT2 inhibitors are the new drugs which have been approved for heart failure with reduced ejection fraction (HFrEF). After the landmark EMPA-REG_OUTCOME, DECLARE TIMI 58, EMPEROR REDUCED and DAPA HF trials, empagliflozin and dapagliflozin have found a place in the management of HFrEF or heart failure. Lets discover what makes them special drugs in heart failure. • ~-~~-~~~-~~-~ • Please watch: ADAPTABLE trial. Aspirin dose for secondary prevention. •    • ADAPTABLE trial. Aspirin dose for sec...   • ~-~~-~~~-~~-~

#############################









Content Report
Youtor.org / YTube video Downloader © 2025

created by www.youtor.org